RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma ; volume:12 ; number:6 ; year:2020 ; extent:17
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 6 (2020) (gesamt 17)

Creator
Smith, Henry G.
Jamal, Kunzah
Dayal, Jasbani HS
Tenev, Tencho
Kyula‐Currie, Joan
Guppy, Naomi
Gazinska, Patrycja
Roulstone, Victoria
Liccardi, Gianmaria
Davies, Emma
Roxanis, Ioannis
Melcher, Alan A.
Hayes, Andrew J.
Inman, Gareth J.
Harrington, Kevin J.
Meier, Pascal

DOI
10.15252/emmm.201910979
URN
urn:nbn:de:101:1-2022062706562075849392
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Smith, Henry G.
  • Jamal, Kunzah
  • Dayal, Jasbani HS
  • Tenev, Tencho
  • Kyula‐Currie, Joan
  • Guppy, Naomi
  • Gazinska, Patrycja
  • Roulstone, Victoria
  • Liccardi, Gianmaria
  • Davies, Emma
  • Roxanis, Ioannis
  • Melcher, Alan A.
  • Hayes, Andrew J.
  • Inman, Gareth J.
  • Harrington, Kevin J.
  • Meier, Pascal

Other Objects (12)

Perioperative treatment of soft-tissue sarcoma

Perioperative treatment of soft-tissue sarcoma

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma

Intraoperative radiation therapy (IORT) in soft-tissue sarcoma

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Relationship of angiogenic and apoptotic activities in soft-tissue sarcoma

Relationship of angiogenic and apoptotic activities in soft-tissue sarcoma

Configuration of soft-tissue sarcoma on MRI correlates with grade of malignancy

Configuration of soft-tissue sarcoma on MRI correlates with grade of malignancy

Customized CRISPR/Cas9 screens to identify novel targets for soft-tissue sarcoma therapy

Hochschulschrift

Customized CRISPR/Cas9 screens to identify novel targets for soft-tissue sarcoma therapy

Lower limb function and quality of life after ILP for soft-tissue sarcoma

Lower limb function and quality of life after ILP for soft-tissue sarcoma

Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!

Advances in soft-tissue sarcoma – There are no mistakes, only lessons to learn!

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice

Evaluating [225Ac]Ac-FAPI-46 for the treatment of soft-tissue sarcoma in mice

Related objects